BIOJECT MEDICAL TECHNOLOGIES INC

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2015-06-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2015-03-31

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending 2014-12-31

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2014-09-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2014-06-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2014-03-31

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending 2013-12-31

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2013-09-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2013-06-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2013-03-31

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

None

None

Exempt (Private) Offering

None

Exempt (Private) Offering

Exempt (Private) Offering

Exempt (Private) Offering

Notice of termination of registration of a class of securities under Section 12(g)

Form for registration of a class of securities pursuant to Section 12(g)

Exempt (Private) Offering

LIFE SCIENCES OPPORTUNITIES FUND II LP: Major Shareholders

FLYNN EDWARD L: Major Shareholders

Logomasini Mark: Major Shareholders

SANDERS MORRIS HARRIS INC.: Statement of changes in beneficial ownership of securities

Logomasini Mark: Statement of changes in beneficial ownership of securities

FLYNN EDWARD L: Statement of changes in beneficial ownership of securities

Tierney David S: Statement of changes in beneficial ownership of securities

FARRELL CHRISTINE: Statement of changes in beneficial ownership of securities

STOUT RICHARD: Statement of changes in beneficial ownership of securities

LIFE SCIENCES OPPORTUNITIES FUND II LP: Major Shareholders

Registration Withdrawal Request

General form of registration statement for all companies including face-amount certificate companies

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(3)

Registration statement for specified transactions by certain issuers

Registration statement for specified transactions by certain issuers

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.